SCHEMBL901068

SCHEMBL901068

CC(C)(c1ccc(CO)o1)c1ccc(CO)o1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
TDP1 Q9NUW8 2/20 0.42
TSHR P16473 2/20 0.42
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 3/20 0.35
CYP2A6 P11509 1/20 0.34
CYP2C19 P33261 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
KLF10 Q13118 1/20 0.31
G6PC1 P35575 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL418855 0.86 ALDH1A1 (0.42) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
SCHEMBL9224957 0.77 ALDH1A1 (0.42) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
SCHEMBL19681453 0.77
SCHEMBL10983582 0.77 CYP2D6 (0.41) CYP2A6CYP2C19CYP1A2CYP2C9
SCHEMBL183551 0.74
SCHEMBL28633235 0.73 ALDH1A1 (0.42) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
SCHEMBL10025526 0.73 ALDH1A1 (0.42) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
SCHEMBL29111193 0.72 ALDH1A1 (0.54) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
SCHEMBL30688993 0.72 ALDH1A1 (0.54) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2
Methoxymethane SCHEMBL28429768 0.70 ALDH1A1 (0.48) ALDH1A1TDP1TSHRKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391795-B2 Polymerizable composition, and copolycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2025-08-19 US claimed
US-12162982-B2 Highly bio-based polycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2024-12-10 US claimed
US-20240166814-A1 POLYESTERAMIDE RESIN, MANUFACTURING METHOD OF THE SAME, AND BIAXIALLY STRETCHED FILM INCLUDING THE SAME SK CHEMICALS CO., LTD. (KR) 2024-05-23 US claimed
WO-2024085502-A1 RESIN COMPOSITION COMPRISING POLYESTERAMIDE RESIN AND MOLDED ARTICLE THEREOF 에스케이케미칼 주식회사 2024-04-25 WO claimed
EP-3872112-B1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME SK CHEMICALS CO LTD (KR) 2023-07-19 EP claimed
WO-2022235008-A1 POLYESTERAMIDE RESIN, MANUFACTURING METHOD THEREOF, AND BIAXIALLY STRETCHED FILM INCLUDING SAME 에스케이케미칼 주식회사 2022-11-10 WO claimed
US-20210380759-A1 POLYMERIZABLE COMPOSITION, AND COPOLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME SK CHEMICALS CO., LTD. (KR) 2021-12-09 US claimed
US-20210380760-A1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME SK CHEMICALS CO., LTD. (KR) 2021-12-09 US claimed
WO-2020085686-A1 POLYMERIZABLE COMPOSITION, AND COPOLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME 에스케이케미칼 주식회사 2020-04-30 WO claimed
WO-2020085662-A1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME 에스케이케미칼 주식회사 2020-04-30 WO claimed
US-9309209-B2 Derivative of epichlorohydrin of natural origin SOLVAY SA (BE) 2016-04-12 US claimed
US-12473398-B2 Highly heat-resistant polycarbonate ester and preparation method therefor SK CHEMICALS CO., LTD. (KR) 2025-11-18 US disclosed
US-12391795-B2 Polymerizable composition, and copolycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2025-08-19 US disclosed
US-12162982-B2 Highly bio-based polycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2024-12-10 US disclosed
US-20240166814-A1 POLYESTERAMIDE RESIN, MANUFACTURING METHOD OF THE SAME, AND BIAXIALLY STRETCHED FILM INCLUDING THE SAME SK CHEMICALS CO., LTD. (KR) 2024-05-23 US disclosed
EP-2621911-A1 DERIVATIVE OF EPICHLOROHYDRIN OF NATURAL ORIGIN SOLVAY SA (BE) 2013-08-07 EP disclosed
US-20130184477-A1 Derivative of epichlorohydrin of natural origin SOLVAY SA (BE) 2013-07-18 US disclosed
US-20120220742-A1 Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2012-08-30 US disclosed
US-20120220742-A1 Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2012-08-30 US disclosed
WO-2012041816-A1 DERIVATIVE OF EPICHLOROHYDRIN OF NATURAL ORIGIN SOLVAY SA (BE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220742-A1 Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same FASN, DCXR, CBR3 ALDH1A1 2009/4885TDP1 3418/4885TSHR 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.